Advise patients to read the FDA-approved patient labeling (Instructions for Use)1
Click on each Step below to see full administration instructions.
Patients should make sure their hands are clean and dry before handling
Instruct patients to fold the foil pouch along the solid line at the top. While keeping the top of the pouch folded over at the solid line, patients should tear down at the slit along the arrow on the side of the pouch to open.1
Patients should remove
Advise patients to place
The patient should close their mouth and swallow saliva normally as
Mitsubishi Tanabe Pharma America, Inc. is committed to advancing treatment options for people living with ALS.
Discover another treatment option to consider in your patients' ALS journeysLearn More
Important Safety Information
Warnings and Precautions
The use of
Interstitial Lung Disease
The most common adverse reactions (incidence greater than or equal to 5% and greater than placebo) of
Use in Specific Populations
Based on animal data, riluzole may cause fetal harm. Women should be advised of a possible risk to the fetus associated with use of
Japanese patients are more likely to have higher riluzole concentrations, and thus may be at a greater risk of adverse reactions.
To report suspected adverse reactions or product complaints, contact Mitsubishi Tanabe Pharma America, Inc. at 1-888-292-0058. You may also report suspected adverse reactions to the FDA at 1-800-FDA-1088 or
Please see the full
Prescribing Information for